Skip to main content

Advertisement

Table 1 Characteristics of the patients in the different groups

From: Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells

  Healthy Disease controls Patients with RA
Number of individuals 152 236 347
Female), n (%) 107 (70.4) 115 (48.7) 277 (79.8)
Age, median (range) 57 (23–71) 47 (18–85) 58 (21 − 94)
Anti-CCP2, n (%) 5 (3.3) 10 (4.2) 250 (72.0)
Anti-cit-Fib protein, n (%) NA NA 190 (54.9)
  1. RA rheumatoid arthritis, CCP cyclic citrullinated peptides, cit-Fib citrullinated fibrinogen, NA data not available